Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» gene therapy
gene therapy
Cell & Gene Therapy Space Gears Up for First CRISPR Approval
Cell & Gene Therapy Space Gears Up for First CRISPR Approval
BioSpace
CRISPR
gene therapy
cell therapy
sickle cell disease
exa-cel
Vertex Pharmaceuticals
CRISPR Therapeutics
Flag link:
Bayer adds a new life science incubator in China
Bayer adds a new life science incubator in China
Pharmaphorum
Bayer
Co.Lab
incubators
China
oncology
cell therapy
gene therapy
Flag link:
Krystal's topical gene therapy gains steam, prompting analyst group to boost sales projection
Krystal's topical gene therapy gains steam, prompting analyst group to boost sales projection
Fierce Biotech
Krystal Biotech
gene therapy
Flag link:
Lexeo drops share price at last minute in attempt to raise $100M IPO
Lexeo drops share price at last minute in attempt to raise $100M IPO
Fierce Biotech
Lexeo Therapeutics
IPOs
gene therapy
Flag link:
Sarepta enjoys early sales ramp for DMD gene therapy, maintains confidence in label expansion
Sarepta enjoys early sales ramp for DMD gene therapy, maintains confidence in label expansion
Fierce Pharma
Sarepta Therapeutics
DMD
Duchenne Muscular Dystrophy
Elevidys
gene therapy
Flag link:
Two Sickle Cell Disease Gene Therapies May Soon Be Approved By FDA
Two Sickle Cell Disease Gene Therapies May Soon Be Approved By FDA
Forbes
sickle cell disease
gene therapy
lovo-cel
exa-cel
Vertex Pharmaceutical
CRISPR Therapeutics
Bluebird Bio
Flag link:
AstraZeneca Drops $245M on Cell and Gene Therapies in Deal with Cellectis
AstraZeneca Drops $245M on Cell and Gene Therapies in Deal with Cellectis
BioSpace
AstraZeneca
Cellectis
cell therapy
gene therapy
Flag link:
FDA panel says Vertex/CRISPR to assess safety risks of gene therapy in follow-up study
FDA panel says Vertex/CRISPR to assess safety risks of gene therapy in follow-up study
Yahoo/Reuters
Vertex Pharmaceuticals
CRISPR Therapeutics
FDA
gene therapy
exa-cel
Flag link:
Sarepta’s disappointing data put the FDA in a difficult spot
Sarepta’s disappointing data put the FDA in a difficult spot
Stat
Sarepta Therapeutics
Duchenne Muscular Dystrophy
DMD
FDA
gene therapy
Flag link:
Sarepta gene therapy for Duchenne misses main goal of key study
Sarepta gene therapy for Duchenne misses main goal of key study
BioPharma Dive
Sarepta Therapeutics
gene therapy
Duchenne Muscular Dystrophy
clinical trials
FDA
Elevidys
Flag link:
Bluebird bio to sell sickle cell FDA voucher for $103 mln if therapy approved
Bluebird bio to sell sickle cell FDA voucher for $103 mln if therapy approved
Reuters
Bluebird Bio
priority review vouchers
sickle cell disease
gene therapy
Flag link:
ThermoGenesis opens cell and gene therapy facility in Sacramento, US
ThermoGenesis opens cell and gene therapy facility in Sacramento, US
Pharmaceutical Business Review
Thermogenesis
cell therapy
gene therapy
California
Flag link:
Roche builds gene therapy portfolio with SpliceBio deal
Roche builds gene therapy portfolio with SpliceBio deal
Pharmaphorum
Roche
Spark Therapeutics
SpliceBio
gene therapy
inherited retinal disease
Flag link:
Gene therapy maker UniQure to cut about 20% of workforce
Gene therapy maker UniQure to cut about 20% of workforce
Reuters
uniQure
gene therapy
layoffs
Flag link:
Bluebird taps Lonza to boost manufacturing capacity for its gene therapies Zynteglo, Skysona
Bluebird taps Lonza to boost manufacturing capacity for its gene therapies Zynteglo, Skysona
Fierce Pharma
Bluebird Bio
gene therapy
Lonza
drug manufacturing
CDMOs
Flag link:
Taysha ends work on gene therapy after Astellas walks away, FDA requests randomized trial
Taysha ends work on gene therapy after Astellas walks away, FDA requests randomized trial
Fierce Biotech
Astellas
Taysha Gene Therapies
gene therapy
FDA
Flag link:
Orchard nears FDA decision on rare disease gene therapy
Orchard nears FDA decision on rare disease gene therapy
BioPharma Dive
Orchard Therapeutics
gene therapy
metachromatic leukodystrophy
FDA
Flag link:
Have Million-Dollar Gene Therapies Finally Reached An Inflection Point?
Have Million-Dollar Gene Therapies Finally Reached An Inflection Point?
Investors Business Daily
gene therapy
Flag link:
AlveoGene debuts to develop inhaled gene therapy technology
AlveoGene debuts to develop inhaled gene therapy technology
Pharmaphorum
Alvogene
UK
startups
lentiviral vectors
gene therapy
drug delivery
Flag link:
Rocket boosted as FDA alignment on pivotal gene therapy trial design sends stock skyward
Rocket boosted as FDA alignment on pivotal gene therapy trial design sends stock skyward
Fierce Biotech
Rocket Pharmaceuticals
gene therapy
FDA
clinical trials
RP-A501
Danon disease
Flag link:
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »